{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T05:30:08Z","timestamp":1766467808276},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.transproceed.2015.12.055","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T11:09:19Z","timestamp":1461928159000},"page":"352-358","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study"],"prefix":"10.1016","volume":"48","author":[{"given":"V.","family":"Morabito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Poli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Ruberto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Pretagostini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.B.","family":"Berloco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2015.12.055_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic Liver Disease. Practice Guideline Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology","volume":"51","author":"O'Shea","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":"Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2015.12.055_bib4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1053\/gast.1996.v110.pm8964410","article-title":"Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone","volume":"110","author":"Mathurin","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib5","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/gut.2004.050781","article-title":"Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score","volume":"54","author":"Forrest","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.transproceed.2015.12.055_bib6","first-page":"567","article-title":"Alcoholic hepatitis: its therapy and prognosis","volume":"4","author":"Galambos","year":"1972","journal-title":"Prog Liver Dis"},{"key":"10.1016\/j.transproceed.2015.12.055_bib7","first-page":"210","article-title":"Prognostic factors in alcoholic liver disease. VA Cooperative Study Group","volume":"86","author":"Chedid","year":"1991","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(86)80006-X","article-title":"Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage","volume":"2","author":"Pares","year":"1986","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/bmj.282.6270.1140","article-title":"Do women develop alcoholic liver disease more readily than men?","volume":"282","author":"Saunders","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.transproceed.2015.12.055_bib10","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib11","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A\u00a0double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/hep.20344","article-title":"Infliximab and alcoholic hepatitis","volume":"40","author":"Mookerjee","year":"2004","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.transproceed.2015.12.055_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1746.2011.07005.x","article-title":"Granulocytapheresis and plasma exchange for severe alcoholic hepatitis","volume":"27","author":"Horie","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"Suppl 12","key":"10.1016\/j.transproceed.2015.12.055_bib14","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1097\/01.alc.0000192300.52559.04","article-title":"Severe alcoholic hepatitis in Japan: prognosis and therapy","volume":"29","author":"Horie","year":"2005","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.transproceed.2015.12.055_bib15","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.clinre.2011.07.005","article-title":"Therapeutic strategies for severe alcoholic hepatitis","volume":"35","author":"Horie","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib16","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1016\/j.transproceed.2012.06.040","article-title":"Management of hepatitis C virus infection in liver transplantation with Adacolumn apheresis","volume":"44","author":"Novelli","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2015.12.055_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jca.1000","article-title":"Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study","volume":"16","author":"Shimoyama","year":"2001","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2015.12.055_bib18","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1111\/j.1572-0241.2002.07029.x","article-title":"Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis","volume":"97","author":"Tsukada","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib19","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.3748\/wjg.v16.i39.4905","article-title":"Alcoholic hepatitis 2010: A clinician's guide to diagnosis and therapy","volume":"16","author":"Koulaouzidis","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00007611-199102000-00036","article-title":"High mortality among patients with the leukemoid reaction and alcoholic hepatitis","volume":"84","author":"Mitchell","year":"1991","journal-title":"South Med J"},{"key":"10.1016\/j.transproceed.2015.12.055_bib22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archinte.151.3.509","article-title":"Effect of marked peripheral leukocytosis on the leukocyte count in ascites","volume":"151","author":"Antillon","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.transproceed.2015.12.055_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/j.1572-0241.2005.41509.x","article-title":"Immune responses to ethanol metabolites and cytokine profiles differentiate alcoholics with or without liver disease","volume":"100","author":"Latvala","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib24","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM200011163432007","article-title":"Cytokines in alcoholic and nonalcoholic steatohepatitis","volume":"343","author":"Tilg","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2015.12.055_bib25","first-page":"A441","article-title":"Clinical and cytokine response to anti-TNF antibody therapy in severe alcoholic hepatitis","volume":"34","author":"Tilg","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","article-title":"Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes","volume":"7","author":"Saniabadi","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.transproceed.2015.12.055_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2010.04279.x","article-title":"The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review","volume":"163","author":"Hanai","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jca.21299","article-title":"Effects of preoperative leukocytapheresis on inflammatory cytokines following surgery for ulcerative colitis: a prospective randomized study","volume":"29","author":"Bamba","year":"2014","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.transproceed.2015.12.055_bib29","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1023\/A:1015330816364","article-title":"Immunomodulatory effects of granulocyte and monocytes adsorption apheresis as a treatment for patients with ulcerative colitis","volume":"47","author":"Kashiwagi","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.transproceed.2015.12.055_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00011-004-1253-5","article-title":"Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin","volume":"53","author":"Takeda","year":"2004","journal-title":"Inflamm Res"},{"key":"10.1016\/j.transproceed.2015.12.055_bib31","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1572-0241.2004.30432.x","article-title":"Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis","volume":"99","author":"Hanai","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib32","first-page":"449","article-title":"Elevated plasma interleukin-6 and increased severity and mortality in alcoholic hepatitis","volume":"84","author":"Sheron","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib33","first-page":"307","article-title":"Cytokines\u2013central factors in alcoholic liver disease","volume":"27","author":"Neuman","year":"2003","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.transproceed.2015.12.055_bib34","series-title":"Fundamental Immunology","first-page":"1051","article-title":"Inflammation","author":"Rosenberg","year":"1999"},{"key":"10.1016\/j.transproceed.2015.12.055_bib35","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/ibd.21260","article-title":"Mucosal healing in patients with ulcerative colitis during a course of selective leukocytapheresis therapy: a prospective cohort study","volume":"16","author":"Yamamoto","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.transproceed.2015.12.055_bib36","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.4049\/jimmunol.144.7.2609","article-title":"Cytokine-induced gene expression of a neutrophil chemotactic factor\/IL-8 in human hepatocytes","volume":"144","author":"Thornton","year":"1990","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0168-8278(96)80156-5","article-title":"Serum levels of interleukin-8 in alcoholic liver disease: relationship with disease stage, biochemical parameters and survival","volume":"24","author":"Huang","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib38","first-page":"41","article-title":"Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration","volume":"18","author":"Sheron","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2015.12.055_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40364-015-0046-z","article-title":"Prognostic models for alcoholic hepatitis","volume":"3","author":"Rahimi","year":"2015","journal-title":"Biomarker Res"},{"key":"10.1016\/j.transproceed.2015.12.055_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00004836-200405000-00012","article-title":"The role of the discriminant factor in the assessment and treatment of alcoholic hepatitis","volume":"38","author":"Kulkarni","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.transproceed.2015.12.055_bib41","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/apt.12654","article-title":"Nine scoring models for short-term mortality in alcoholic hepatitis: cross validation in a biopsy-proven cohort","volume":"39","author":"Papastergiou","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2015.12.055_bib42","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-2-2","article-title":"Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis","volume":"2","author":"Sheth","year":"2002","journal-title":"BMC Gastroenterol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T16:51:52Z","timestamp":1692291112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0041134516000774"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.12.055","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adacolumn Granulocyte-Apheresis for Alcoholic Hepatitis: Preliminary Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2015.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}